Cargando…

5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN

Detalles Bibliográficos
Autores principales: Cristina Zuccato, C.Z., Lucia Carmela Cosenza, L.C.C., Gianni Sacchetti, G.S., Riccardo Rondanin, R.R., Daniele Simoni, D.S., Marco Prosdocimi, M.P., Lipucci di Paola, M.L.P., Alessia Finotti, A.F., Roberto Gambari, R.G., Ilaria Lampronti, I.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112597/
http://dx.doi.org/10.1097/01.HS9.0000928252.78758.54
_version_ 1785027655856291840
author Cristina Zuccato, C.Z.
Lucia Carmela Cosenza, L.C.C.
Gianni Sacchetti, G.S.
Riccardo Rondanin, R.R.
Daniele Simoni, D.S.
Marco Prosdocimi, M.P.
Lipucci di Paola, M.L.P.
Alessia Finotti, A.F.
Roberto Gambari, R.G.
Ilaria Lampronti, I.L.
author_facet Cristina Zuccato, C.Z.
Lucia Carmela Cosenza, L.C.C.
Gianni Sacchetti, G.S.
Riccardo Rondanin, R.R.
Daniele Simoni, D.S.
Marco Prosdocimi, M.P.
Lipucci di Paola, M.L.P.
Alessia Finotti, A.F.
Roberto Gambari, R.G.
Ilaria Lampronti, I.L.
author_sort Cristina Zuccato, C.Z.
collection PubMed
description
format Online
Article
Text
id pubmed-10112597
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101125972023-04-19 5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN Cristina Zuccato, C.Z. Lucia Carmela Cosenza, L.C.C. Gianni Sacchetti, G.S. Riccardo Rondanin, R.R. Daniele Simoni, D.S. Marco Prosdocimi, M.P. Lipucci di Paola, M.L.P. Alessia Finotti, A.F. Roberto Gambari, R.G. Ilaria Lampronti, I.L. Hemasphere Poster Presentations Lippincott Williams & Wilkins 2023-04-10 /pmc/articles/PMC10112597/ http://dx.doi.org/10.1097/01.HS9.0000928252.78758.54 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster Presentations
Cristina Zuccato, C.Z.
Lucia Carmela Cosenza, L.C.C.
Gianni Sacchetti, G.S.
Riccardo Rondanin, R.R.
Daniele Simoni, D.S.
Marco Prosdocimi, M.P.
Lipucci di Paola, M.L.P.
Alessia Finotti, A.F.
Roberto Gambari, R.G.
Ilaria Lampronti, I.L.
5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
title 5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
title_full 5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
title_fullStr 5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
title_full_unstemmed 5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
title_short 5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
title_sort 5613423 treatment of erythroid precursor cells from β-thalassemic patients with isoxazole derivatives: potent induction of fetal hemoglobin
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112597/
http://dx.doi.org/10.1097/01.HS9.0000928252.78758.54
work_keys_str_mv AT cristinazuccatocz 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT luciacarmelacosenzalcc 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT giannisacchettigs 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT riccardorondaninrr 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT danielesimonids 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT marcoprosdocimimp 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT lipuccidipaolamlp 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT alessiafinottiaf 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT robertogambarirg 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin
AT ilarialamprontiil 5613423treatmentoferythroidprecursorcellsfrombthalassemicpatientswithisoxazolederivativespotentinductionoffetalhemoglobin